Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2025-01-07 00:00:00 ET · period of report 2025-01-03 · accession 0001453687-25-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-01-07 | 2025-01-03+ | RNAC | Kurtoglu Metin | CTO | S - Sale | $16.78 | -4,875 | 62.3K | -7% | -$81.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-03 | S | D | 2,417 | $16.72 | 64,716 | D | — | — | (F1) Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. |
| 2 | Common | Common Stock | 2025-01-06 | S | D | 2,458 | $16.83 | 62,258 | D | — | — | (F1) Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. |